Sayre Therapeutics
Sayre Therapeutics is a healthcare company founded in 2015 that brings innovative treatments for rare, orphan, and life-threatening diseases to India and the broader SAARC region. It works across clinical research, regulatory strategy, and commercialization and market access, partnering with global licensors to bring US-, EU-, and Japan-approved drugs, drug-delivery devices, and diagnostics to South Asian markets under local regulatory standards. Its portfolio spans special-access and commercially approved products, diagnostics, biosimilars, and niche generics. Surfaced as a portfolio company of Accel and added to the API Evangelist network. The company publishes no public developer portal, API, or technical documentation.
Sayre Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Pharmaceuticals, Biotechnology, and Clinical Research.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API